The health care sector closed the day up 2.6%. Cardium Therapeutics Inc ( CXM), Anthera Pharmaceuticals Inc ( ANTH), Adeona Pharmaceuticals Inc ( AEN), and BG Medicine Inc ( BGMD) were all winners today within the health care sector with Johnson & Johnson ( JNJ) being today's featured health care winner. Johnson & Johnson rose $1.30 (2.1%) to $64.43 on light volume. Throughout the day, 6.9 million shares of Johnson & Johnson exchanged hands as compared to its average daily volume of 15.6 million shares. Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Johnson & Johnson has a market cap of $170.9 billion and is part of the drugs industry. The company has a P/E ratio of 14.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 1.6% year to date as of the close of trading on Friday. TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Johnson & Johnson Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.